This tool contains data exploration of neural signal activity in various cancers, including neural signal activity and molecular subtypes, and identification of differentially expressed genes and functions involved in diverse subtypes.
This tool includes identification of neural-immune interaction patterns and construction of regulatory network between neural signals and immune signatures.
This tool analyzes the correlation between neural signals and clinical features, including patient information, clinical stage and genetic variation features.
This tool identifies spatial characteristics of neural signals in cancers and the relevance of neural signals and spatial neighborhood.
This tool explores the association between neural signals and drug sensitivity (IC50 value), and the effectiveness of neural signal activity-based model classifiers in distinguishing the sensitivity and resistance of the drug.
This tool examines the relevance of neural signals and survival prognosis of patients, including OS (Overall Survival), PFS (Progression Free Survival), DFS (Disease Free Survival) and DSS (Disease Specific Survival).








